Short answer
Zymeworks Inc. (ZYME) filed an 8-K current report with the SEC on March 2, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q4 and full-year 2025 earnings released March 2, 2026: full results in Exhibit 99.1.
Zymeworks Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 earnings released March 2, 2026: full results in Exhibit 99.1
- Period covered: three months and full year ended December 31, 2025
Item 7.01 · Regulation FD Disclosure
- Reg FD notice listing official disclosure channels: SEC filings, press releases, website, and social media (X @ZymeworksInc, LinkedIn)
- Investors should monitor ir.zymeworks.com and social channels: material news may appear there first before broader distribution
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Zymeworks Inc. 8-K filings
Get the next ZYME 8-K as it lands
Follow ZYME for push alerts, or ask the research agent what this filing means.